LNTH
Lantheus Holdings Inc
NASDAQ: LNTH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$81.17
-2.85% today
Updated 2026-04-29
Market cap
$5.28B
P/E ratio
23.80
P/S ratio
3.43x
EPS (TTM)
$3.41
Dividend yield
—
52W range
$47 – $109
Volume
1.0M
Lantheus Holdings Inc (LNTH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $23.21M | $-372000.00 | $-15.57M | $11.59M | $21.76M | $49.64M | $54.78M | $61.19M | $80.38M | $16.40M | $53.92M | $281.78M | $305.26M | $544.75M | $390.14M |
| Capital expenditures | $7.69M | $7.92M | $5.01M | $8.14M | $13.15M | $7.40M | $17.54M | $20.13M | $22.06M | $12.47M | $12.14M | $18.35M | $46.55M | $51.63M | $36.09M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $-969000.00 | $1.24M | $578000.00 | $1.03M | $2.00M | $2.52M | $5.93M | $8.72M | $12.49M | $14.07M | $15.93M | $29.26M | $50.51M | $76.39M | $85.56M |
| Free cash flow | $15.52M | $-8.29M | $-20.58M | $3.45M | $8.61M | $42.24M | $37.23M | $41.06M | $58.32M | $3.92M | $41.78M | $263.43M | $258.70M | $493.13M | $354.05M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $101.12M | $3.52M | $123000.00 | — | $0.00 | $0.00 | $0.00 | — | $2.45M | $2.13M | $2.05M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $8.86M | $22.58M | $25.11M | $37.11M | $-20.56M | $-10.38M | $18.27M | $316.93M | — | — | — |